MetadataShow full item record
DescriptionNews release from the UMB School of Medicine announcing the SOM's participation in a phase 3 clinical trial of a COVID-19 vaccine developed by biotechnology company, Novavax, Inc., based in Gaithersburg, MD.
KeywordCoronavirus Disease 2019 (COVID-19)
University of Maryland, Baltimore. School of Medicine